Meeting ReportOncology, Basic Science Track
Safety, Pharmacokinetics and Dosimetry of a Long-lasting Radiolabeled Somatostatin Analogue 177Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors: A Phase 1 First-in-human Study
Jingjing Zhang, Gang Niu, Hao Wang, Orit Jacobson, Yuejuan Cheng, Jie Zang, Fang Li, Chunmei Bai, Zhaohui Zhu and Xiaoyuan Chen
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 118;
Jingjing Zhang
7Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences & PUMC Beijing China
Gang Niu
4NIH Bethesda MD United States
Hao Wang
6Department of Nuclear Medicine Peking Union Medical College Hospital Beijing China
Orit Jacobson
2National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH) Bethesda MD United States
Yuejuan Cheng
8Oncology Department Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) Beijing China
Jie Zang
6Department of Nuclear Medicine Peking Union Medical College Hospital Beijing China
Fang Li
6Department of Nuclear Medicine Peking Union Medical College Hospital Beijing China
Chunmei Bai
5Department of Medical Oncology Peking Union Medical College Hospital Beijing China
Zhaohui Zhu
1Department of Nuclear Medicine, Peking Union Medical College Hospital Beijing China
Xiaoyuan Chen
3NIBIB/NIH Bethesda MD United States
In this issue
Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
Safety, Pharmacokinetics and Dosimetry of a Long-lasting Radiolabeled Somatostatin Analogue 177Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors: A Phase 1 First-in-human Study
Jingjing Zhang, Gang Niu, Hao Wang, Orit Jacobson, Yuejuan Cheng, Jie Zang, Fang Li, Chunmei Bai, Zhaohui Zhu, Xiaoyuan Chen
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 118;
Safety, Pharmacokinetics and Dosimetry of a Long-lasting Radiolabeled Somatostatin Analogue 177Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors: A Phase 1 First-in-human Study
Jingjing Zhang, Gang Niu, Hao Wang, Orit Jacobson, Yuejuan Cheng, Jie Zang, Fang Li, Chunmei Bai, Zhaohui Zhu, Xiaoyuan Chen
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 118;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.